Kim R. Tsuchimoto
Chief Financial Officer, RAPTOR PHARMACEUTICALS CORP.
Companies
- Monopar TherapeuticsBoard member Apr 4, 2023 to now1
- Monopar TherapeuticsChief financial officer Jan 8, 2018 to Jul 2, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Monopar Therapeutics MNPR11,486 shares3$812.7K at $70.76Aug 28, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 26, 2026Sold 590 shares at $113.84 of Monopar Therapeutics3
- Aug 26, 2026Sold 602 shares at $112.93 of Monopar Therapeutics3
- Aug 26, 2026Sold 1,098 shares at $111.84 of Monopar Therapeutics3
- Aug 26, 2026Sold 590 shares at $113.84 of Monopar Therapeutics4
- Aug 26, 2026Sold 700 shares at $110.65 of Monopar Therapeutics3
- Aug 26, 2026Sold 602 shares at $112.93 of Monopar Therapeutics4
- Aug 26, 2026Sold 615 shares at $109.56 of Monopar Therapeutics3
- Aug 26, 2026Sold 1,098 shares at $111.84 of Monopar Therapeutics4
- Aug 26, 2026Sold 485 shares at $108.83 of Monopar Therapeutics3
- Aug 26, 2026Sold 700 shares at $110.65 of Monopar Therapeutics4
- Aug 26, 2026Exercised options 2,035 shares at $14.00 of Monopar Therapeutics3
- Aug 26, 2026Sold 615 shares at $109.56 of Monopar Therapeutics4
- Aug 26, 2026Exercised options 2,055 shares at $30.00 of Monopar Therapeutics3
- Aug 26, 2026Sold 485 shares at $108.83 of Monopar Therapeutics4
- Jul 14, 2025Sold 8,904 shares at $40.00 of Monopar Therapeutics5
- Jul 14, 2025Exercised 8,904 shares at $0.01 of Monopar Therapeutics5
- Jun 30, 2024Shares withheld for tax 2,998 shares at $0.73 of Monopar Therapeutics6
- Jun 30, 2024Exercised options 9,957 shares of Monopar Therapeutics6
- Mar 31, 2024Shares withheld for tax 4,082 shares at $0.68 of Monopar Therapeutics7
- Mar 31, 2024Exercised options 9,956 shares of Monopar Therapeutics7
- Jan 1, 2024Shares withheld for tax 505 shares at $0.34 of Monopar Therapeutics8
- Jan 1, 2024Exercised options 1,231 shares of Monopar Therapeutics8
- Dec 31, 2023Shares withheld for tax 4,073 shares at $0.34 of Monopar Therapeutics8
- Dec 31, 2023Exercised options 9,957 shares of Monopar Therapeutics8
- Sep 30, 2023Shares withheld for tax 3,444 shares at $0.62 of Monopar Therapeutics9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMonopar Therapeutics, Board member
- 2
- 3
- 4SEC EDGARForm 4 filed Aug 27, 2026
- 5SEC EDGARForm 4 filed Jul 16, 2025
- 6SEC EDGARForm 4 filed Jul 2, 2024
- 7SEC EDGARForm 4 filed Apr 2, 2024
- 8SEC EDGARForm 4 filed Jan 3, 2024
- 9SEC EDGARForm 4 filed Oct 3, 2023